Cite
AK002, A NOVEL SIGLEC-8 ANTIBODY DEPLETES HUMAN EOSINOPHILS AND INHIBITS ANAPHYLAXIS IN HUMANIZED MICE
MLA
R. Falahati, et al. “Ak002, a Novel Siglec-8 Antibody Depletes Human Eosinophils and Inhibits Anaphylaxis in Humanized Mice.” Annals of Allergy, Asthma & Immunology, vol. 121, Nov. 2018, p. S20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........48b63ecaf061f67d880f5dba03d1455e&authtype=sso&custid=ns315887.
APA
R. Falahati, E. Brock, C. Bebbington, N. Tomasevic, B. Youngblood, Paul J. Bryce, A. Chang, M. Brehm, & J. Leung. (2018). Ak002, a Novel Siglec-8 Antibody Depletes Human Eosinophils and Inhibits Anaphylaxis in Humanized Mice. Annals of Allergy, Asthma & Immunology, 121, S20.
Chicago
R. Falahati, E. Brock, C. Bebbington, N. Tomasevic, B. Youngblood, Paul J. Bryce, A. Chang, M. Brehm, and J. Leung. 2018. “Ak002, a Novel Siglec-8 Antibody Depletes Human Eosinophils and Inhibits Anaphylaxis in Humanized Mice.” Annals of Allergy, Asthma & Immunology 121 (November): S20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........48b63ecaf061f67d880f5dba03d1455e&authtype=sso&custid=ns315887.